Elcelyx Therapeutics Company

Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.

Employee Number: 11-50
Investors Number: 6
Funding Status: Late Stage Venture
Headquarters: San Diego, California, United States
Technology: Small Molecules
Estimated Revenue: $1M to $10M
Founded Date: 2010
Last Funding Type: Series E
Investor Type: For Profit
Total Funding: $96.8M
Industry: PharmTech